Annual revenue:
$40.09B+$2.39B(+6.35%)Summary
- As of today (August 18, 2025), GSK annual revenue is $40.09 billion, with the most recent change of +$2.39 billion (+6.35%) on December 31, 2024.
- During the last 3 years, GSK annual revenue has risen by +$6.13 billion (+18.04%).
- GSK annual revenue is now -11.81% below its all-time high of $45.46 billion, reached on December 31, 2007.
Performance
GSK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$10.67B+$1.20B(+12.70%)Summary
- As of today (August 18, 2025), GSK quarterly revenue is $10.67 billion, with the most recent change of +$1.20 billion (+12.70%) on June 30, 2025.
- Over the past year, GSK quarterly revenue has increased by +$719.55 million (+7.23%).
- GSK quarterly revenue is now -19.38% below its all-time high of $13.23 billion, reached on December 31, 2009.
Performance
GSK Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$40.95B+$719.55M(+1.79%)Summary
- As of today (August 18, 2025), GSK TTM revenue is $40.95 billion, with the most recent change of +$719.55 million (+1.79%) on June 30, 2025.
- Over the past year, GSK TTM revenue has increased by +$1.37 billion (+3.46%).
- GSK TTM revenue is now -11.67% below its all-time high of $46.36 billion, reached on March 31, 2010.
Performance
GSK TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GSK Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.3% | +7.2% | +3.5% |
| 3 y3 years | +18.0% | +22.7% | +10.7% |
| 5 y5 years | -6.9% | +12.7% | -7.1% |
GSK Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.0% | at high | +26.3% | at high | +17.0% |
| 5 y | 5-year | -8.3% | +18.0% | -7.6% | +30.6% | -7.1% | +17.0% |
| alltime | all time | -11.8% | +2916.1% | -19.4% | +2245.9% | -11.7% | +7477.2% |
GSK Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $10.67B(+12.7%) | $40.95B(+1.8%) |
| Mar 2025 | - | $9.47B(-9.0%) | $40.23B(+0.3%) |
| Dec 2024 | $40.09B(+6.3%) | $10.40B(-0.1%) | $40.10B(+1.0%) |
| Sep 2024 | - | $10.42B(+4.7%) | $39.69B(+0.3%) |
| Jun 2024 | - | $9.95B(+6.6%) | $39.58B(+2.5%) |
| Mar 2024 | - | $9.34B(-6.5%) | $38.62B(+2.4%) |
| Dec 2023 | $37.70B(+4.4%) | $9.99B(-3.1%) | $37.73B(+3.7%) |
| Sep 2023 | - | $10.31B(+14.7%) | $36.39B(+3.1%) |
| Jun 2023 | - | $8.99B(+6.4%) | $35.29B(+0.8%) |
| Mar 2023 | - | $8.45B(-2.4%) | $34.99B(-3.3%) |
| Dec 2022 | $36.12B(+6.3%) | $8.65B(-6.0%) | $36.19B(-2.4%) |
| Sep 2022 | - | $9.20B(+5.9%) | $37.07B(+0.2%) |
| Jun 2022 | - | $8.69B(-9.9%) | $37.00B(+1.4%) |
| Mar 2022 | - | $9.64B(+1.1%) | $36.47B(-1.6%) |
| Dec 2021 | $33.96B(-22.3%) | $9.54B(+4.4%) | $37.06B(-5.1%) |
| Sep 2021 | - | $9.13B(+11.8%) | $39.06B(-5.0%) |
| Jun 2021 | - | $8.16B(-20.2%) | $41.10B(-3.1%) |
| Mar 2021 | - | $10.23B(-11.4%) | $42.40B(-3.2%) |
| Dec 2020 | $43.73B(+1.5%) | $11.54B(+3.3%) | $43.78B(+0.2%) |
| Sep 2020 | - | $11.17B(+18.0%) | $43.70B(-0.9%) |
| Jun 2020 | - | $9.46B(-18.5%) | $44.10B(-1.3%) |
| Mar 2020 | - | $11.61B(+1.4%) | $44.67B(+3.8%) |
| Dec 2019 | $43.06B(+4.8%) | $11.45B(-1.0%) | $43.03B(+2.1%) |
| Sep 2019 | - | $11.57B(+15.3%) | $42.13B(+2.5%) |
| Jun 2019 | - | $10.04B(+0.6%) | $41.10B(+0.2%) |
| Mar 2019 | - | $9.98B(-5.4%) | $41.01B(-0.2%) |
| Dec 2018 | $41.10B(+5.7%) | $10.54B(-0.0%) | $41.08B(+1.0%) |
| Sep 2018 | - | $10.55B(+6.1%) | $40.67B(+0.7%) |
| Jun 2018 | - | $9.94B(-1.1%) | $40.38B(+1.4%) |
| Mar 2018 | - | $10.05B(-0.8%) | $39.82B(+2.3%) |
| Dec 2017 | $38.87B(+3.6%) | $10.13B(-1.2%) | $38.92B(+2.0%) |
| Sep 2017 | - | $10.26B(+9.5%) | $38.15B(+1.0%) |
| Jun 2017 | - | $9.37B(+2.4%) | $37.79B(+0.3%) |
| Mar 2017 | - | $9.15B(-2.4%) | $37.69B(+0.9%) |
| Dec 2016 | $37.53B(+2.7%) | $9.37B(-5.3%) | $37.36B(-0.4%) |
| Sep 2016 | - | $9.90B(+6.8%) | $37.52B(+1.3%) |
| Jun 2016 | - | $9.27B(+5.1%) | $37.05B(+0.5%) |
| Mar 2016 | - | $8.82B(-7.4%) | $36.88B(+0.9%) |
| Dec 2015 | $36.55B(-3.5%) | $9.53B(+1.2%) | $36.55B(-0.7%) |
| Sep 2015 | - | $9.42B(+3.6%) | $36.80B(+0.2%) |
| Jun 2015 | - | $9.10B(+7.1%) | $36.74B(-0.8%) |
| Mar 2015 | - | $8.49B(-13.3%) | $37.05B(-2.2%) |
| Dec 2014 | $37.88B(-8.7%) | $9.79B(+4.7%) | $37.89B(-3.8%) |
| Sep 2014 | - | $9.35B(-0.6%) | $39.37B(-1.8%) |
| Jun 2014 | - | $9.41B(+0.8%) | $40.11B(-1.8%) |
| Mar 2014 | - | $9.33B(-17.3%) | $40.86B(-1.7%) |
| Dec 2013 | $41.51B(-0.9%) | $11.28B(+11.8%) | $41.57B(+0.8%) |
| Sep 2013 | - | $10.09B(-0.7%) | $41.26B(-0.5%) |
| Jun 2013 | - | $10.16B(+1.2%) | $41.48B(-0.2%) |
| Mar 2013 | - | $10.04B(-8.5%) | $41.54B(-0.9%) |
| Dec 2012 | $41.88B(-4.6%) | $10.97B(+6.4%) | $41.94B(-0.1%) |
| Sep 2012 | - | $10.31B(+0.8%) | $41.99B(-2.6%) |
| Jun 2012 | - | $10.22B(-2.0%) | $43.11B(-1.7%) |
| Mar 2012 | - | $10.43B(-5.4%) | $43.85B(-0.3%) |
| Dec 2011 | $43.90B(+0.2%) | $11.03B(-3.5%) | $43.96B(-0.7%) |
| Sep 2011 | - | $11.43B(+4.3%) | $44.26B(+1.9%) |
| Jun 2011 | - | $10.96B(+3.8%) | $43.46B(+1.1%) |
| Mar 2011 | - | $10.55B(-6.9%) | $42.99B(-1.9%) |
| Dec 2010 | $43.82B(-1.6%) | $11.33B(+6.6%) | $43.83B(-4.2%) |
| Sep 2010 | - | $10.63B(+1.3%) | $45.73B(-1.0%) |
| Jun 2010 | - | $10.49B(-7.8%) | $46.19B(-0.4%) |
| Mar 2010 | - | $11.38B(-14.0%) | $46.36B(+3.8%) |
| Dec 2009 | $44.52B(-0.7%) | $13.23B(+19.4%) | $44.68B(+6.3%) |
| Sep 2009 | - | $11.08B(+4.0%) | $42.02B(+0.3%) |
| Jun 2009 | - | $10.66B(+9.9%) | $41.89B(-2.3%) |
| Mar 2009 | - | $9.70B(-8.2%) | $42.87B(-3.6%) |
| Dec 2008 | $44.82B(-1.4%) | $10.57B(-3.5%) | $44.47B(-3.6%) |
| Sep 2008 | - | $10.95B(-5.9%) | $46.12B(-0.2%) |
| Jun 2008 | - | $11.64B(+3.0%) | $46.23B(+0.8%) |
| Mar 2008 | - | $11.31B(-7.4%) | $45.86B(+0.8%) |
| Dec 2007 | $45.46B(+6.3%) | $12.21B(+10.4%) | $45.48B(+1.8%) |
| Sep 2007 | - | $11.07B(-1.8%) | $44.68B(+1.1%) |
| Jun 2007 | - | $11.27B(+3.1%) | $44.19B(+1.5%) |
| Mar 2007 | - | $10.93B(-4.2%) | $43.54B(+1.7%) |
| Dec 2006 | $42.75B(+8.6%) | $11.41B(+7.8%) | $42.80B(+2.6%) |
| Sep 2006 | - | $10.58B(-0.5%) | $41.71B(+2.0%) |
| Jun 2006 | - | $10.63B(+4.3%) | $40.90B(+2.2%) |
| Mar 2006 | - | $10.19B(-1.3%) | $40.00B(+1.7%) |
| Dec 2005 | $39.36B | $10.32B(+5.7%) | $39.33B(+1.4%) |
| Sep 2005 | - | $9.76B(+0.4%) | $38.77B(+2.3%) |
| Jun 2005 | - | $9.73B(+2.2%) | $37.92B(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $9.52B(-2.5%) | $37.16B(+1.6%) |
| Dec 2004 | $36.60B(+4.5%) | $9.76B(+9.6%) | $36.57B(+1.6%) |
| Sep 2004 | - | $8.91B(-0.8%) | $35.98B(+0.3%) |
| Jun 2004 | - | $8.98B(+0.6%) | $35.88B(+0.8%) |
| Mar 2004 | - | $8.92B(-2.8%) | $35.60B(+1.6%) |
| Dec 2003 | $35.03B(+10.0%) | $9.18B(+4.2%) | $35.05B(+0.8%) |
| Sep 2003 | - | $8.80B(+1.2%) | $34.78B(+3.0%) |
| Jun 2003 | - | $8.70B(+3.9%) | $33.75B(+2.4%) |
| Mar 2003 | - | $8.37B(-6.0%) | $32.96B(+3.4%) |
| Dec 2002 | $31.83B(+7.9%) | $8.91B(+14.6%) | $31.88B(+2.6%) |
| Sep 2002 | - | $7.77B(-1.7%) | $31.08B(+2.0%) |
| Jun 2002 | - | $7.91B(+8.6%) | $30.48B(+2.1%) |
| Mar 2002 | - | $7.29B(-10.1%) | $29.84B(+1.2%) |
| Dec 2001 | $29.50B(+7.9%) | $8.10B(+12.9%) | $29.49B(+2.9%) |
| Sep 2001 | - | $7.18B(-1.4%) | $28.67B(+2.2%) |
| Jun 2001 | - | $7.28B(+4.9%) | $28.04B(+1.2%) |
| Mar 2001 | - | $6.94B(-4.7%) | $27.70B(+1.4%) |
| Dec 2000 | $27.35B(+0.7%) | $7.28B(+11.2%) | $27.33B(+15.0%) |
| Sep 2000 | - | $6.55B(-5.6%) | $23.77B(+13.9%) |
| Jun 2000 | - | $6.94B(+5.6%) | $20.87B(+20.5%) |
| Mar 2000 | - | $6.57B(+76.8%) | $17.32B(+23.4%) |
| Dec 1999 | $27.16B(+105.3%) | $3.72B(+1.9%) | $14.04B(+1.9%) |
| Sep 1999 | - | $3.65B(+7.6%) | $13.78B(+1.8%) |
| Jun 1999 | - | $3.39B(+3.1%) | $13.53B(+1.5%) |
| Mar 1999 | - | $3.29B(-5.0%) | $13.34B(+0.8%) |
| Dec 1998 | $13.23B(+1.2%) | $3.46B(+1.7%) | $13.23B(+3.2%) |
| Sep 1998 | - | $3.40B(+6.5%) | $12.83B(+1.2%) |
| Jun 1998 | - | $3.19B(+0.5%) | $12.68B(-0.8%) |
| Mar 1998 | - | $3.18B(+4.1%) | $12.78B(-1.2%) |
| Dec 1997 | $13.07B(+0.4%) | $3.05B(-6.1%) | $12.94B(-16.0%) |
| Sep 1997 | - | $3.25B(-1.1%) | $15.39B(-3.8%) |
| Jun 1997 | - | $3.29B(-1.4%) | $16.01B(+0.6%) |
| Mar 1997 | - | $3.34B(-39.4%) | $15.91B(+0.5%) |
| Dec 1996 | $13.01B(+17.9%) | $5.51B(+42.5%) | $15.82B(+53.4%) |
| Sep 1996 | - | $3.87B(+21.3%) | $10.31B(+14.5%) |
| Jun 1996 | - | $3.19B(-2.1%) | $9.01B(+5.8%) |
| Mar 1996 | - | $3.26B(+27.0%) | $8.51B(-18.1%) |
| Dec 1995 | $11.04B(+30.3%) | - | - |
| Sep 1995 | - | $2.56B(-4.8%) | $10.40B(+0.3%) |
| Jun 1995 | - | $2.69B(+6.5%) | $10.37B(+7.4%) |
| Mar 1995 | - | $2.53B(-3.3%) | $9.65B(+2.9%) |
| Dec 1994 | - | $2.61B(+3.3%) | $9.38B(+5.6%) |
| Sep 1994 | - | $2.53B(+28.2%) | $8.89B(+5.2%) |
| Jun 1994 | $8.47B(+6.8%) | $1.97B(-12.7%) | $8.45B(+3.6%) |
| Mar 1994 | - | $2.26B(+6.6%) | $8.16B(+0.4%) |
| Dec 1993 | - | $2.12B(+1.3%) | $8.12B(+4.0%) |
| Sep 1993 | - | $2.09B(+24.6%) | $7.81B(+3.1%) |
| Jun 1993 | $7.93B(+10.1%) | $1.68B(-24.6%) | $7.58B(+4.8%) |
| Mar 1993 | - | $2.23B(+23.3%) | $7.23B(+3.5%) |
| Dec 1992 | - | $1.81B(-2.9%) | $6.98B(-0.6%) |
| Sep 1992 | - | $1.86B(+39.8%) | $7.02B(-0.2%) |
| Jun 1992 | $7.20B(+14.5%) | $1.33B(-32.9%) | $7.04B(-5.5%) |
| Mar 1992 | - | $1.98B(+7.2%) | $7.44B(+6.7%) |
| Dec 1991 | - | $1.85B(-1.3%) | $6.97B(+7.0%) |
| Sep 1991 | - | $1.87B(+7.8%) | $6.52B(+8.4%) |
| Jun 1991 | $6.29B(+21.5%) | $1.74B(+14.9%) | $6.01B(+3.3%) |
| Mar 1991 | - | $1.51B(+8.7%) | $5.82B(+3.8%) |
| Dec 1990 | - | $1.39B(+1.5%) | $5.61B(+3.7%) |
| Sep 1990 | - | $1.37B(-11.5%) | $5.41B(+3.5%) |
| Jun 1990 | $5.17B(+17.3%) | $1.55B(+19.3%) | $5.23B(+5.3%) |
| Mar 1990 | - | $1.30B(+8.8%) | $4.96B(+6.0%) |
| Dec 1989 | - | $1.19B(+0.5%) | $4.68B(+4.1%) |
| Sep 1989 | - | $1.19B(-7.6%) | $4.50B(+3.9%) |
| Jun 1989 | $4.41B(+22.2%) | $1.29B(+26.2%) | $4.33B(+2.3%) |
| Mar 1989 | - | $1.02B(+1.1%) | $4.23B(+3.8%) |
| Dec 1988 | - | $1.01B(-1.1%) | $4.08B(+5.0%) |
| Sep 1988 | - | $1.02B(-14.4%) | $3.89B(+4.2%) |
| Jun 1988 | $3.61B(+36.0%) | $1.19B(+37.7%) | $3.73B(+13.1%) |
| Mar 1988 | - | $863.72M(+6.1%) | $3.30B(+4.7%) |
| Dec 1987 | - | $814.42M(-5.5%) | $3.15B(+6.1%) |
| Sep 1987 | - | $862.23M(+13.6%) | $2.97B(+6.8%) |
| Jun 1987 | $2.66B(+29.0%) | $758.67M(+6.2%) | $2.78B(+12.3%) |
| Mar 1987 | - | $714.30M(+12.9%) | $2.47B(+7.5%) |
| Dec 1986 | - | $632.59M(-6.0%) | $2.30B(+3.8%) |
| Sep 1986 | - | $672.76M(+48.0%) | $2.22B(+6.3%) |
| Jun 1986 | $2.06B(+42.0%) | $454.71M(-16.1%) | $2.09B(+27.9%) |
| Mar 1986 | - | $542.04M(-1.2%) | $1.63B(+49.8%) |
| Dec 1985 | - | $548.45M(+1.5%) | $1.09B(+101.5%) |
| Sep 1985 | - | $540.44M | $540.44M |
| Jun 1985 | $1.45B(+9.1%) | - | - |
| Jun 1984 | $1.33B | - | - |
FAQ
- What is GSK plc annual revenue?
- What is the all time high annual revenue for GSK plc?
- What is GSK plc annual revenue year-on-year change?
- What is GSK plc quarterly revenue?
- What is the all time high quarterly revenue for GSK plc?
- What is GSK plc quarterly revenue year-on-year change?
- What is GSK plc TTM revenue?
- What is the all time high TTM revenue for GSK plc?
- What is GSK plc TTM revenue year-on-year change?
What is GSK plc annual revenue?
The current annual revenue of GSK is $40.09B
What is the all time high annual revenue for GSK plc?
GSK plc all-time high annual revenue is $45.46B
What is GSK plc annual revenue year-on-year change?
Over the past year, GSK annual revenue has changed by +$2.39B (+6.35%)
What is GSK plc quarterly revenue?
The current quarterly revenue of GSK is $10.67B
What is the all time high quarterly revenue for GSK plc?
GSK plc all-time high quarterly revenue is $13.23B
What is GSK plc quarterly revenue year-on-year change?
Over the past year, GSK quarterly revenue has changed by +$719.55M (+7.23%)
What is GSK plc TTM revenue?
The current TTM revenue of GSK is $40.95B
What is the all time high TTM revenue for GSK plc?
GSK plc all-time high TTM revenue is $46.36B
What is GSK plc TTM revenue year-on-year change?
Over the past year, GSK TTM revenue has changed by +$1.37B (+3.46%)